Tryn Stimart - Jun 9, 2021 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role: Chief Legal Officer
Signature: /s/ Tryn Stimart
Stock symbol: ABCL
Transactions as of: Jun 9, 2021
Transactions value $: -$25,500,000
Form type: 4
Date filed: 6/10/2021, 05:01 PM
Previous filing: Jun 9, 2021
Next filing: Dec 9, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABCL	Common Shares	Sale	-$25.5M	-1M	-99.98%	$25.50	250	Jun 9, 2021	Direct	F1, F2
holding	ABCL	Common Shares						250	Jun 9, 2021	By spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50.
F2	The sale of the shares reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act"), to the extent of 500 Shares, with the purchase by the Reporting Person of 250 Shares at a price of $20 per share on December 15, 2020, and the purchase by the Reporting Person's spouse of 250 Shares at a price of $20 per share on December 15, 2020, as reported previously on the Reporting Person's Form 4 filed on December 17, 2020. The Reporting Person has voluntarily disgorged to the Issuer the full amount of the resulting statutory profit calculated pursuant to Section 16(b) of the Exchange Act.

Content

On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50.

The sale of the shares reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act"), to the extent of 500 Shares, with the purchase by the Reporting Person of 250 Shares at a price of $20 per share on December 15, 2020, and the purchase by the Reporting Person's spouse of 250 Shares at a price of $20 per share on December 15, 2020, as reported previously on the Reporting Person's Form 4 filed on December 17, 2020. The Reporting Person has voluntarily disgorged to the Issuer the full amount of the resulting statutory profit calculated pursuant to Section 16(b) of the Exchange Act.